ABSTRACT
Studies of intraoperative angiography have shown residual distal thrombi in 30% of patients undergoing emboloectomy. Both streptokinase and urokinase have been used intraoperatively to Iyse such thrombi. Side effects inclinde anaphylaxis, wound hoematoma, and systemic hypofibrinogenaemia. In this study recombinant tissue plasminogcn activator [rtPA] was used to lyse residual thrombi in 18 patients after transfemoral embolectomy. Complete lysis was achieved in 10 patients [55.5%], partial lysis in 5 patients [27.8%] and only 3 patients [16.7%] had no response. Limb salvage rate was 72.2%. There were no reported cases of allergic reactions, wound haematomas, or coagulation problems. The study shows that intraoperative tissue plasmoinogen activator [rtPA] is safe and effective in losing residual postembolectomy thrombi. Its use may avoid the need for more distal exploration
Subject(s)
Humans , Male , Female , Lower Extremity , Tissue Plasminogen Activator , Embolectomy/statistics & numerical data , Limb Salvage , FibrinogenABSTRACT
Se presentan los resultados obtenidos en una serie consecutiva de 165 pacientes con oclusión arterial aguda de los miembros (102 embolias y 63 trombosis) sometidos a 186 operaciones de urgencia en los últimos 9 años. Del análisis de nuestra casuística se desprende que existe una buena posibilidad de salvar un miembro isquemiado, en la medida en que se tome a tiempo la correcta decisión de encarar su adecuado tratamiento quirúrgico de urgencia.